Disease | Risk Allele | Score vda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
Malignant neoplasm of breast
|
0.870 | CausalMutation | CLINVAR | ||||||||
Breast Carcinoma
|
0.770 | CausalMutation | CLINVAR | ||||||||
ovarian neoplasm
|
0.730 | CausalMutation | CLINVAR | ||||||||
Malignant neoplasm of ovary
|
0.730 | GeneticVariation | UNIPROT | ||||||||
Mammary Neoplasms
|
0.700 | CausalMutation | CLINVAR | ||||||||
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1
|
0.700 | CausalMutation | CLINVAR | ||||||||
FANCONI ANEMIA, COMPLEMENTATION GROUP S
|
0.700 | CausalMutation | CLINVAR | ||||||||
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1
|
0.700 | CausalMutation | CLINVAR | ||||||||
PANCREATIC CANCER, SUSCEPTIBILITY TO, 4
|
0.700 | CausalMutation | CLINVAR | ||||||||
Hereditary Breast and Ovarian Cancer Syndrome
|
0.700 | CausalMutation | CLINVAR | A high-throughput functional complementation assay for classification of BRCA1 missense variants. | 23867111 | 2013 | |||||
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1
|
0.700 | CausalMutation | CLINVAR | A high-throughput functional complementation assay for classification of BRCA1 missense variants. | 23867111 | 2013 | |||||
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1
|
0.700 | CausalMutation | CLINVAR | A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS). | 21990134 | 2012 | |||||
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1
|
0.700 | CausalMutation | CLINVAR | A yeast recombination assay to characterize human BRCA1 missense variants of unknown pathological significance. | 18680205 | 2009 | |||||
Hereditary Breast and Ovarian Cancer Syndrome
|
0.700 | CausalMutation | CLINVAR | A yeast recombination assay to characterize human BRCA1 missense variants of unknown pathological significance. | 18680205 | 2009 | |||||
Neoplastic Syndromes, Hereditary
|
0.700 | CausalMutation | CLINVAR | Analysis of BRCA1 variants in double-strand break repair by homologous recombination and single-strand annealing. | 23161852 | 2013 | |||||
Hereditary Breast and Ovarian Cancer Syndrome
|
0.700 | CausalMutation | CLINVAR | Analysis of BRCA1 variants in double-strand break repair by homologous recombination and single-strand annealing. | 23161852 | 2013 | |||||
Hereditary Breast and Ovarian Cancer Syndrome
|
0.700 | CausalMutation | CLINVAR | Assessment of human Nter and Cter BRCA1 mutations using growth and localization assays in yeast. | 21922593 | 2011 | |||||
Hereditary Breast and Ovarian Cancer Syndrome
|
0.700 | CausalMutation | CLINVAR | Assessment of rare BRCA1 and BRCA2 variants of unknown significance using hierarchical modeling. | 21520273 | 2011 | |||||
Hereditary Breast and Ovarian Cancer Syndrome
|
0.700 | CausalMutation | CLINVAR | Average age-specific cumulative risk of breast cancer according to type and site of germline mutations in BRCA1 and BRCA2 estimated from multiple-case breast cancer families attending Australian family cancer clinics. | 12601471 | 2003 | |||||
Hereditary Breast and Ovarian Cancer Syndrome
|
0.700 | CausalMutation | CLINVAR | Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex. | 12732733 | 2003 | |||||
Hereditary Breast and Ovarian Cancer Syndrome
|
0.700 | CausalMutation | CLINVAR | BRCA1 : BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair. | 14976165 | 2004 | |||||
Hereditary Breast and Ovarian Cancer Syndrome
|
0.700 | CausalMutation | CLINVAR | BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families. | 20683152 | 2010 | |||||
Hereditary Breast and Ovarian Cancer Syndrome
|
0.700 | CausalMutation | CLINVAR | BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age. | 11389159 | 2001 | |||||
Hereditary Breast and Ovarian Cancer Syndrome
|
0.700 | CausalMutation | CLINVAR | BRCA1 physically and functionally interacts with ATF1. | 10945975 | 2000 | |||||
Hereditary Breast and Ovarian Cancer Syndrome
|
0.700 | CausalMutation | CLINVAR | BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistance. | 22172724 | 2011 |